# Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

> **NCT01508221** · PHASE2 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 31 (actual)

## Conditions studied

- Brain Metastasis

## Interventions

- **DRUG:** Trental
- **DIETARY_SUPPLEMENT:** Vitamin E

## Key facts

- **NCT ID:** NCT01508221
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-02-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508221, "Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01508221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*